APA (7th ed.) Citation

L, F., K, Y., S, Z., Z, C., Y, B., & T, L. (2022). Anti-PD-1 Therapy is Beneficial for the Survival of Patients with Oral Squamous Cell Carcinoma. Dove Medical Press.

Chicago Style (17th ed.) Citation

L, Feng, Yin K, Zhang S, Chen Z, Bao Y, and Li T. Anti-PD-1 Therapy Is Beneficial for the Survival of Patients with Oral Squamous Cell Carcinoma. Dove Medical Press, 2022.

MLA (9th ed.) Citation

L, Feng, et al. Anti-PD-1 Therapy Is Beneficial for the Survival of Patients with Oral Squamous Cell Carcinoma. Dove Medical Press, 2022.